181 related articles for article (PubMed ID: 24436008)
1. Expression of metalloproteinases 2 and 9 and tissue inhibitors 1 and 2 as predictors of lymph node metastases in oropharyngeal squamous cell carcinoma.
Burduk PK; Bodnar M; Sawicki P; Szylberg Ł; Wiśniewska E; Kaźmierczak W; Martyńska M; Marszałek A
Head Neck; 2015 Mar; 37(3):418-22. PubMed ID: 24436008
[TBL] [Abstract][Full Text] [Related]
2. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.
Bodnar M; Szylberg Ł; Kazmierczak W; Marszalek A
J Oral Pathol Med; 2015 Jul; 44(6):437-43. PubMed ID: 25244188
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
[TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
Xie M; Sun Y; Li Y
Laryngoscope; 2004 Dec; 114(12):2243-8. PubMed ID: 15564854
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
6. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
[TBL] [Abstract][Full Text] [Related]
7. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS
J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188
[TBL] [Abstract][Full Text] [Related]
8. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis.
Kurahara S; Shinohara M; Ikebe T; Nakamura S; Beppu M; Hiraki A; Takeuchi H; Shirasuna K
Head Neck; 1999 Oct; 21(7):627-38. PubMed ID: 10487950
[TBL] [Abstract][Full Text] [Related]
9. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
Zhou CY; Yao JF; Chen XD
Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of lymph node and tumor matrix metalloproteinase expression in the analysis of metastatic periampullary tumors.
McKenna GJ; Meneghetti A; Chen YL; Mui AL; Ong C; Scudamore CH; McMaster WR; Owen DA; Chung SW
J Surg Oncol; 2005 Jun; 90(4):239-46. PubMed ID: 15906368
[TBL] [Abstract][Full Text] [Related]
11. [The effects of MMPs and TIMPs on the metastasis of oral squamous cell carcinoma to neck lymph nodes].
Liu G; Li J; Li Z; Chen X
Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Aug; 19(4):216-8, 224. PubMed ID: 12539723
[TBL] [Abstract][Full Text] [Related]
12. Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinoma.
Määttä M; Santala M; Soini Y; Turpeenniemi-Hujanen T; Talvensaari-Mattila A
Acta Obstet Gynecol Scand; 2010 Mar; 89(3):380-4. PubMed ID: 20109015
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas.
Ondruschka C; Buhtz P; Motsch C; Freigang B; Schneider-Stock R; Roessner A; Boltze C
Pathol Res Pract; 2002; 198(8):509-15. PubMed ID: 12389993
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
Li Y; Ma J; Guo Q; Duan F; Tang F; Zheng P; Zhao Z; Lu G
Dis Esophagus; 2009; 22(8):664-7. PubMed ID: 19191857
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of cervical lymph node metastasis of oropharyngeal carcinoma in relation to extent of the primary tumor].
Pfreundner L; Pahnke J; Wameling S
Laryngorhinootologie; 1996 Apr; 75(4):223-30. PubMed ID: 8688128
[TBL] [Abstract][Full Text] [Related]
16. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G
Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691
[TBL] [Abstract][Full Text] [Related]
17. Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue.
Guttman D; Stern Y; Shpitzer T; Ulanovski D; Druzd T; Feinmesser R
Oral Oncol; 2004 Sep; 40(8):798-803. PubMed ID: 15288834
[TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
19. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.
Lim YC; Koo BS; Lee JS; Lim JY; Choi EC
Laryngoscope; 2006 Jul; 116(7):1148-52. PubMed ID: 16826050
[TBL] [Abstract][Full Text] [Related]
20. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
